Rivaroxaban population pharmacokinetic and pharmacodynamic modeling in Iranian patients.
What is Known and Objective: Although predictable pharmacokinetic and pharmacodynamic of rivaroxaban allow fixed dosing regimens without routine coagulation monitoring, there is still the necessity to monitor and predict the effects of rivaroxaban in specific conditions and different populations. Th...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 47; no. 8; pp. 1284 - 1293 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |